Pfizer Inc.

NYSE:PFE   3:59:58 PM EDT
41.81
+0.13 (+0.31%)
4:40:01 PM EDT: $41.83 +0.02 (+0.05%)
Products

U.S. FDA's Woodcock Says Agency Intends To Complete Pfizer's BLA Review Far In Advance Of PDUFA Goal Date

Published: 07/16/2021 18:33 GMT
Pfizer Inc. (PFE) - U.S. FDA's Woodcock Says Review of Pfizer's Biologics License Application Has Been Ongoing - Tweet.
U.S. FDA's Woodcock Says Agency Intends to Complete Pfizer's Biologics License Application Review Far in Advance of the PDUFA Goal Date- Tweet.
((reuters.
Briefs@thomsonreuters.
Com;)).